Given the high percentage of p53 mutations in ovarian tumors [6] and the recent evidence that p53 and Smads interact to regulate metastasis in breast carcinoma cells [8], the role of mutant p53 in response to TGFβ signaling in ovarian cancer was investigated. This evidence concerns the gene TP53 and ovarian neoplasm.